No price history available.

Based on consensus from external analysts. Not Kvantra's opinion.

RELX PLC is a global enterprise that furnishes professional and business clients with sophisticated information-based analytics and decision-making instruments across North America, Europe, and other international markets. Its operations are organized into four primary divisions: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment delivers advanced analytical and decision-support tools by integrating public and industry-specific content with cutting-edge technology and algorithms, empowering clients to evaluate and predict risks effectively. Through its Scientific, Technical & Medical segment, the company provides essential information and analytical insights, enabling institutions and professionals to foster scientific progress and enhance healthcare worldwide. The Legal segment offers comprehensive legal, regulatory, and commercial information alongside analytics, assisting customers in making well-informed decisions and boosting their operational efficiency. Furthermore, the Exhibitions segment manages a dynamic events portfolio, combining in-person interactions with data-driven and digital solutions to help attendees understand markets, source products, and finalize business transactions. Founded in 1903 and headquartered in London, United Kingdom, the organization operated as Reed Elsevier PLC before adopting the RELX PLC name in July 2015.

• Thomson Reuters Corporation
• Cintas Corporation
• Experian plc
• Haitian Flav
• Copart, Inc.
• Brambles Limited
• RB Global, Inc.
• UL Solutions Inc.